Point-of-Care Glucose Testing Market By Product Type (Lancing Devices and Strips, Blood-Glucose Meter), By Application (Type-1 Diabetes, Type-2 Diabetes), By End User (Hospitals and Clinics, Home Care Settings, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
The point-of-care glucose testing market was valued at $3,003.30 million in 2022 and is estimated to reach $4,793.22 million by 2032, exhibiting a CAGR of 4.8% from 2023 to 2032.
Point-of-care testing refers to medical diagnostic tests that are performed at or near the patient, rather than being sent to a laboratory for analysis. Point-of-care glucose testing is a type of medical diagnostic test that measures the level of glucose (sugar) in a patient's blood. This test is typically performed using a blood glucose meter, which is a portable device that provides a rapid measurement of a patient's blood glucose level. Point-of-care glucose testing is commonly used in the management of diabetes, a chronic condition in which the body is unable to regulate blood glucose levels effectively. Patients with diabetes often need to monitor their blood glucose levels regularly to ensure that they are within a healthy range, and to make treatment decisions based on their results.
Major factors that drive the growth of the point-of-care glucose testing market include rapid advancements in glucose testing devices and increase in number of patients suffering from diabetic disorders, such as diabetic nephropathy and diabetes mellitus. For instance, according to the 10th edition of the International Diabetes Federation (IDF)’s Diabetes Atlas, in 2021, 537 million adults (20-79 years) are living with diabetes worldwide. Over 3 in 4 adults with diabetes live in low- and middle-income countries. Diabetes is responsible for 6.7 million deaths in 2021, 1 every 5 seconds. It caused at least $966 billion dollars in health expenditure which is a 316% increase over the last 15 years. 541 million adults have Impaired Glucose Tolerance (IGT), which places them at high risk of type 2 diabetes.
Furthermore, surge in awareness among the population about self-management of diabetes contributes to the growth of point-of-care glucose testing market growth. In addition, the development of affordable and effective glucose testing devices and government initiatives to provide diabetes care facilities drive the growth of the point-of-care glucose testing market. For instance, in January 2022 Roche launched its new point-of-care blood glucose monitor designed for hospital professionals, with a companion device shaped like a touchscreen smartphone that will run its own apps. The hand-held Cobas pulse includes an automated glucose test strip reader as well as a camera and touchscreen for logging other diagnostic results, all in a hardened body that can be cleaned with disinfectants. It’s designed to be used with patients of all ages, including neonates and people in intensive care.
However, the accuracy concerns of glucose testing meter are expected to hamper the point-of-care glucose testing market growth. On the contrary, the surge in healthcare expenditure and rise in number of adoptions of key strategies by key players are expected to create immense opportunities for expansion of the global market in the future.
The point-of-care glucose testing market is segmented on the basis of product type, application, end user, and region. On the basis of product type, the market is classified into lancing devices & strips, and blood-glucose meter. The blood-glucose meter segment is further bifurcated into Lifescan OneTouch Ultra & Lifescan OneTouch Verio; Accu-Chek Aviva Plus & Accu-Chek; FreeStyle Lite & FreeStyle precision neo; Contour Next; and others. On the basis of application, the market is classified into type-1 diabetes, and type-2 diabetes. As per end user, it is segregated into hospitals & clinics, home care settings, and others.
Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
North America is anticipated to dominate the market for point-of-care glucose testing devices and is expected to continue the trend throughout the forecast period. This is attributed to the surge in the geriatric population that is suffering from diabetes, strong presence of key players, and availability of advanced healthcare system & modern medical technologies. However, Asia-Pacific is expected to register a noteworthy CAGR throughout the forecast period, owing to the presence of diabetes patient population, rise in demand for point-of-care glucose testing devices due to high population base, and increase in public–private investments for unmet medical needs.
Major players profiled in the report are Abbott Laboratories, ACON Laboratories, Inc., Ascensia Diabetes Care Holdings AG, EKF Diagnostics Holdings plc, F. Hoffmann-La Roche Ltd., Nipro, Nova Biomedical, Platinum Equity Advisors, LLC (Lifescan, Inc.), Prodigy Diabetes Care, LLC, and Trividia Health, Inc. The major players in the market have adopted agreement, collaboration, partnership, product development, product approval, and product launch as key developmental strategies to improve the product portfolio of the point-of-care glucose testing market.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the point-of-care glucose testing market analysis from 2022 to 2032 to identify the prevailing point-of-care glucose testing market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the point-of-care glucose testing market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global point-of-care glucose testing market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product Type
Lancing Devices and Strips
Blood-Glucose Meter
Type
Lifescan OneTouch Ultra and Lifescan OneTouch Verio
Accu-Chek Aviva Plus and Accuchek
Freestyle Lite and Freestyle Precission Neo
Contour Next
Others
By Application
Type-1 Diabetes
Type-2 Diabetes
By End User
Hospitals and Clinics
Home Care Settings
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
ACON Laboratories, Inc.
Nipro
Platinum Equity Advisors LLC
Abbott Laboratories
Trividia Health, Inc.
Nova Biomedical Corporation
EKF Diagnostics Holdings plc
Ascensia Diabetes Care Holdings AG
F. Hoffmann-La Roche Ltd.
Prodigy Diabetes Care LLC
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1: INTRODUCTION
- 1.1. Report description
- 1.2. Key market segments
- 1.3. Key benefits to the stakeholders
- 1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET OVERVIEW
- 3.1. Market definition and scope
- 3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
- 3.3. Porter’s five forces analysis
- 3.3.1. Bargaining power of suppliers
- 3.3.2. Bargaining power of buyers
- 3.3.3. Threat of substitutes
- 3.3.4. Threat of new entrants
- 3.3.5. Intensity of rivalry
- 3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.1.1. Increase in the incidence rate of diabetes.
- 3.4.1.2. Rise in geriatric population
- 3.4.1.3. Technological advancements in diabetes monitoring devices
- 3.4.1.4. Rise in risk factors that lead to diabetes
- 3.4.2. Restraints
- 3.4.2.1. Inaccurate results
- 3.4.3. Opportunities
- 3.4.3.1. Increase in awareness for glucose monitoring devices.
- 3.4.3.2. Untapped market opportunities in the developing regions
- 3.5. COVID-19 Impact Analysis on the market
- CHAPTER 4: POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE
- 4.1. Overview
- 4.1.1. Market size and forecast
- 4.2. Lancing Devices and Strips
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.3. Blood-Glucose Meter
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
- 4.3.4. Blood-Glucose Meter Point-of-Care Glucose Testing Market by Type
- CHAPTER 5: POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION
- 5.1. Overview
- 5.1.1. Market size and forecast
- 5.2. Type-1 Diabetes
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
- 5.3. Type-2 Diabetes
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
- CHAPTER 6: POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER
- 6.1. Overview
- 6.1.1. Market size and forecast
- 6.2. Hospitals and Clinics
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
- 6.3. Home Care Settings
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
- 6.4. Others
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country
- CHAPTER 7: POINT-OF-CARE GLUCOSE TESTING MARKET, BY REGION
- 7.1. Overview
- 7.1.1. Market size and forecast By Region
- 7.2. North America
- 7.2.1. Key trends and opportunities
- 7.2.2. Market size and forecast, by Product Type
- 7.2.3. Market size and forecast, by Application
- 7.2.4. Market size and forecast, by End User
- 7.2.5. Market size and forecast, by country
- 7.2.5.1. U.S.
- 7.2.5.1.1. Key market trends, growth factors and opportunities
- 7.2.5.1.2. Market size and forecast, by Product Type
- 7.2.5.1.3. Market size and forecast, by Application
- 7.2.5.1.4. Market size and forecast, by End User
- 7.2.5.2. Canada
- 7.2.5.2.1. Key market trends, growth factors and opportunities
- 7.2.5.2.2. Market size and forecast, by Product Type
- 7.2.5.2.3. Market size and forecast, by Application
- 7.2.5.2.4. Market size and forecast, by End User
- 7.2.5.3. Mexico
- 7.2.5.3.1. Key market trends, growth factors and opportunities
- 7.2.5.3.2. Market size and forecast, by Product Type
- 7.2.5.3.3. Market size and forecast, by Application
- 7.2.5.3.4. Market size and forecast, by End User
- 7.3. Europe
- 7.3.1. Key trends and opportunities
- 7.3.2. Market size and forecast, by Product Type
- 7.3.3. Market size and forecast, by Application
- 7.3.4. Market size and forecast, by End User
- 7.3.5. Market size and forecast, by country
- 7.3.5.1. Germany
- 7.3.5.1.1. Key market trends, growth factors and opportunities
- 7.3.5.1.2. Market size and forecast, by Product Type
- 7.3.5.1.3. Market size and forecast, by Application
- 7.3.5.1.4. Market size and forecast, by End User
- 7.3.5.2. France
- 7.3.5.2.1. Key market trends, growth factors and opportunities
- 7.3.5.2.2. Market size and forecast, by Product Type
- 7.3.5.2.3. Market size and forecast, by Application
- 7.3.5.2.4. Market size and forecast, by End User
- 7.3.5.3. UK
- 7.3.5.3.1. Key market trends, growth factors and opportunities
- 7.3.5.3.2. Market size and forecast, by Product Type
- 7.3.5.3.3. Market size and forecast, by Application
- 7.3.5.3.4. Market size and forecast, by End User
- 7.3.5.4. Italy
- 7.3.5.4.1. Key market trends, growth factors and opportunities
- 7.3.5.4.2. Market size and forecast, by Product Type
- 7.3.5.4.3. Market size and forecast, by Application
- 7.3.5.4.4. Market size and forecast, by End User
- 7.3.5.5. Spain
- 7.3.5.5.1. Key market trends, growth factors and opportunities
- 7.3.5.5.2. Market size and forecast, by Product Type
- 7.3.5.5.3. Market size and forecast, by Application
- 7.3.5.5.4. Market size and forecast, by End User
- 7.3.5.6. Rest of Europe
- 7.3.5.6.1. Key market trends, growth factors and opportunities
- 7.3.5.6.2. Market size and forecast, by Product Type
- 7.3.5.6.3. Market size and forecast, by Application
- 7.3.5.6.4. Market size and forecast, by End User
- 7.4. Asia-Pacific
- 7.4.1. Key trends and opportunities
- 7.4.2. Market size and forecast, by Product Type
- 7.4.3. Market size and forecast, by Application
- 7.4.4. Market size and forecast, by End User
- 7.4.5. Market size and forecast, by country
- 7.4.5.1. Japan
- 7.4.5.1.1. Key market trends, growth factors and opportunities
- 7.4.5.1.2. Market size and forecast, by Product Type
- 7.4.5.1.3. Market size and forecast, by Application
- 7.4.5.1.4. Market size and forecast, by End User
- 7.4.5.2. China
- 7.4.5.2.1. Key market trends, growth factors and opportunities
- 7.4.5.2.2. Market size and forecast, by Product Type
- 7.4.5.2.3. Market size and forecast, by Application
- 7.4.5.2.4. Market size and forecast, by End User
- 7.4.5.3. Australia
- 7.4.5.3.1. Key market trends, growth factors and opportunities
- 7.4.5.3.2. Market size and forecast, by Product Type
- 7.4.5.3.3. Market size and forecast, by Application
- 7.4.5.3.4. Market size and forecast, by End User
- 7.4.5.4. India
- 7.4.5.4.1. Key market trends, growth factors and opportunities
- 7.4.5.4.2. Market size and forecast, by Product Type
- 7.4.5.4.3. Market size and forecast, by Application
- 7.4.5.4.4. Market size and forecast, by End User
- 7.4.5.5. South Korea
- 7.4.5.5.1. Key market trends, growth factors and opportunities
- 7.4.5.5.2. Market size and forecast, by Product Type
- 7.4.5.5.3. Market size and forecast, by Application
- 7.4.5.5.4. Market size and forecast, by End User
- 7.4.5.6. Rest of Asia-Pacific
- 7.4.5.6.1. Key market trends, growth factors and opportunities
- 7.4.5.6.2. Market size and forecast, by Product Type
- 7.4.5.6.3. Market size and forecast, by Application
- 7.4.5.6.4. Market size and forecast, by End User
- 7.5. LAMEA
- 7.5.1. Key trends and opportunities
- 7.5.2. Market size and forecast, by Product Type
- 7.5.3. Market size and forecast, by Application
- 7.5.4. Market size and forecast, by End User
- 7.5.5. Market size and forecast, by country
- 7.5.5.1. Brazil
- 7.5.5.1.1. Key market trends, growth factors and opportunities
- 7.5.5.1.2. Market size and forecast, by Product Type
- 7.5.5.1.3. Market size and forecast, by Application
- 7.5.5.1.4. Market size and forecast, by End User
- 7.5.5.2. Saudi Arabia
- 7.5.5.2.1. Key market trends, growth factors and opportunities
- 7.5.5.2.2. Market size and forecast, by Product Type
- 7.5.5.2.3. Market size and forecast, by Application
- 7.5.5.2.4. Market size and forecast, by End User
- 7.5.5.3. South Africa
- 7.5.5.3.1. Key market trends, growth factors and opportunities
- 7.5.5.3.2. Market size and forecast, by Product Type
- 7.5.5.3.3. Market size and forecast, by Application
- 7.5.5.3.4. Market size and forecast, by End User
- 7.5.5.4. Rest of LAMEA
- 7.5.5.4.1. Key market trends, growth factors and opportunities
- 7.5.5.4.2. Market size and forecast, by Product Type
- 7.5.5.4.3. Market size and forecast, by Application
- 7.5.5.4.4. Market size and forecast, by End User
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top player positioning, 2022
- CHAPTER 9: COMPANY PROFILES
- 9.1. Platinum Equity Advisors LLC
- 9.1.1. Company overview
- 9.1.2. Key Executives
- 9.1.3. Company snapshot
- 9.1.4. Operating business segments
- 9.1.5. Product portfolio
- 9.1.6. Key strategic moves and developments
- 9.2. Nova Biomedical Corporation
- 9.2.1. Company overview
- 9.2.2. Key Executives
- 9.2.3. Company snapshot
- 9.2.4. Operating business segments
- 9.2.5. Product portfolio
- 9.2.6. Key strategic moves and developments
- 9.3. ACON Laboratories, Inc.
- 9.3.1. Company overview
- 9.3.2. Key Executives
- 9.3.3. Company snapshot
- 9.3.4. Operating business segments
- 9.3.5. Product portfolio
- 9.4. Trividia Health, Inc.
- 9.4.1. Company overview
- 9.4.2. Key Executives
- 9.4.3. Company snapshot
- 9.4.4. Operating business segments
- 9.4.5. Product portfolio
- 9.5. Prodigy Diabetes Care LLC
- 9.5.1. Company overview
- 9.5.2. Key Executives
- 9.5.3. Company snapshot
- 9.5.4. Operating business segments
- 9.5.5. Product portfolio
- 9.6. EKF Diagnostics Holdings plc
- 9.6.1. Company overview
- 9.6.2. Key Executives
- 9.6.3. Company snapshot
- 9.6.4. Operating business segments
- 9.6.5. Product portfolio
- 9.6.6. Business performance
- 9.6.7. Key strategic moves and developments
- 9.7. Ascensia Diabetes Care Holdings AG
- 9.7.1. Company overview
- 9.7.2. Key Executives
- 9.7.3. Company snapshot
- 9.7.4. Operating business segments
- 9.7.5. Product portfolio
- 9.7.6. Key strategic moves and developments
- 9.8. Nipro
- 9.8.1. Company overview
- 9.8.2. Key Executives
- 9.8.3. Company snapshot
- 9.8.4. Operating business segments
- 9.8.5. Product portfolio
- 9.8.6. Business performance
- 9.9. F. Hoffmann-La Roche Ltd.
- 9.9.1. Company overview
- 9.9.2. Key Executives
- 9.9.3. Company snapshot
- 9.9.4. Operating business segments
- 9.9.5. Product portfolio
- 9.9.6. Business performance
- 9.9.7. Key strategic moves and developments
- 9.10. Abbott Laboratories
- 9.10.1. Company overview
- 9.10.2. Key Executives
- 9.10.3. Company snapshot
- 9.10.4. Operating business segments
- 9.10.5. Product portfolio
- 9.10.6. Business performance
- 9.10.7. Key strategic moves and developments
- LIST OF TABLES
- TABLE 01. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
- TABLE 02. POINT-OF-CARE GLUCOSE TESTING MARKET FOR LANCING DEVICES AND STRIPS, BY REGION, 2022-2032 ($MILLION)
- TABLE 03. POINT-OF-CARE GLUCOSE TESTING MARKET FOR BLOOD-GLUCOSE METER, BY REGION, 2022-2032 ($MILLION)
- TABLE 04. GLOBAL BLOOD-GLUCOSE METER POINT-OF-CARE GLUCOSE TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 05. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 06. POINT-OF-CARE GLUCOSE TESTING MARKET FOR TYPE-1 DIABETES, BY REGION, 2022-2032 ($MILLION)
- TABLE 07. POINT-OF-CARE GLUCOSE TESTING MARKET FOR TYPE-2 DIABETES, BY REGION, 2022-2032 ($MILLION)
- TABLE 08. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 09. POINT-OF-CARE GLUCOSE TESTING MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2022-2032 ($MILLION)
- TABLE 10. POINT-OF-CARE GLUCOSE TESTING MARKET FOR HOME CARE SETTINGS, BY REGION, 2022-2032 ($MILLION)
- TABLE 11. POINT-OF-CARE GLUCOSE TESTING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
- TABLE 12. POINT-OF-CARE GLUCOSE TESTING MARKET, BY REGION, 2022-2032 ($MILLION)
- TABLE 13. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
- TABLE 14. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 15. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 16. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 17. U.S. POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
- TABLE 18. U.S. POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 19. U.S. POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 20. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
- TABLE 21. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 22. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 23. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
- TABLE 24. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 25. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 26. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
- TABLE 27. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 28. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 29. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 30. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
- TABLE 31. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 32. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 33. FRANCE POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
- TABLE 34. FRANCE POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 35. FRANCE POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 36. UK POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
- TABLE 37. UK POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 38. UK POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 39. ITALY POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
- TABLE 40. ITALY POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 41. ITALY POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 42. SPAIN POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
- TABLE 43. SPAIN POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 44. SPAIN POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 45. REST OF EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
- TABLE 46. REST OF EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 47. REST OF EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 48. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
- TABLE 49. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 50. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 51. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 52. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
- TABLE 53. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 54. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 55. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
- TABLE 56. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 57. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 58. AUSTRALIA POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
- TABLE 59. AUSTRALIA POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 60. AUSTRALIA POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 61. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
- TABLE 62. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 63. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 64. SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
- TABLE 65. SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 66. SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 67. REST OF ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
- TABLE 68. REST OF ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 69. REST OF ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 70. LAMEA POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
- TABLE 71. LAMEA POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 72. LAMEA POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 73. LAMEA POINT-OF-CARE GLUCOSE TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 74. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
- TABLE 75. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 76. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 77. SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
- TABLE 78. SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 79. SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 80. SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
- TABLE 81. SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 82. SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 83. REST OF LAMEA POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
- TABLE 84. REST OF LAMEA POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 85. REST OF LAMEA POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 86. PLATINUM EQUITY ADVISORS LLC: KEY EXECUTIVES
- TABLE 87. PLATINUM EQUITY ADVISORS LLC: COMPANY SNAPSHOT
- TABLE 88. PLATINUM EQUITY ADVISORS LLC: PRODUCT SEGMENTS
- TABLE 89. PLATINUM EQUITY ADVISORS LLC: PRODUCT PORTFOLIO
- TABLE 90. PLATINUM EQUITY ADVISORS LLC: KEY STRATERGIES
- TABLE 91. NOVA BIOMEDICAL CORPORATION: KEY EXECUTIVES
- TABLE 92. NOVA BIOMEDICAL CORPORATION: COMPANY SNAPSHOT
- TABLE 93. NOVA BIOMEDICAL CORPORATION: PRODUCT SEGMENTS
- TABLE 94. NOVA BIOMEDICAL CORPORATION: PRODUCT PORTFOLIO
- TABLE 95. NOVA BIOMEDICAL CORPORATION: KEY STRATERGIES
- TABLE 96. ACON LABORATORIES, INC.: KEY EXECUTIVES
- TABLE 97. ACON LABORATORIES, INC.: COMPANY SNAPSHOT
- TABLE 98. ACON LABORATORIES, INC.: PRODUCT SEGMENTS
- TABLE 99. ACON LABORATORIES, INC.: PRODUCT PORTFOLIO
- TABLE 100. TRIVIDIA HEALTH, INC.: KEY EXECUTIVES
- TABLE 101. TRIVIDIA HEALTH, INC.: COMPANY SNAPSHOT
- TABLE 102. TRIVIDIA HEALTH, INC.: PRODUCT SEGMENTS
- TABLE 103. TRIVIDIA HEALTH, INC.: PRODUCT PORTFOLIO
- TABLE 104. PRODIGY DIABETES CARE LLC: KEY EXECUTIVES
- TABLE 105. PRODIGY DIABETES CARE LLC: COMPANY SNAPSHOT
- TABLE 106. PRODIGY DIABETES CARE LLC: PRODUCT SEGMENTS
- TABLE 107. PRODIGY DIABETES CARE LLC: PRODUCT PORTFOLIO
- TABLE 108. EKF DIAGNOSTICS HOLDINGS PLC: KEY EXECUTIVES
- TABLE 109. EKF DIAGNOSTICS HOLDINGS PLC: COMPANY SNAPSHOT
- TABLE 110. EKF DIAGNOSTICS HOLDINGS PLC: PRODUCT SEGMENTS
- TABLE 111. EKF DIAGNOSTICS HOLDINGS PLC: PRODUCT PORTFOLIO
- TABLE 112. EKF DIAGNOSTICS HOLDINGS PLC: KEY STRATERGIES
- TABLE 113. ASCENSIA DIABETES CARE HOLDINGS AG: KEY EXECUTIVES
- TABLE 114. ASCENSIA DIABETES CARE HOLDINGS AG: COMPANY SNAPSHOT
- TABLE 115. ASCENSIA DIABETES CARE HOLDINGS AG: PRODUCT SEGMENTS
- TABLE 116. ASCENSIA DIABETES CARE HOLDINGS AG: PRODUCT PORTFOLIO
- TABLE 117. ASCENSIA DIABETES CARE HOLDINGS AG: KEY STRATERGIES
- TABLE 118. NIPRO: KEY EXECUTIVES
- TABLE 119. NIPRO: COMPANY SNAPSHOT
- TABLE 120. NIPRO: PRODUCT SEGMENTS
- TABLE 121. NIPRO: PRODUCT PORTFOLIO
- TABLE 122. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
- TABLE 123. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
- TABLE 124. F. HOFFMANN-LA ROCHE LTD.: PRODUCT SEGMENTS
- TABLE 125. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
- TABLE 126. F. HOFFMANN-LA ROCHE LTD.: KEY STRATERGIES
- TABLE 127. ABBOTT LABORATORIES: KEY EXECUTIVES
- TABLE 128. ABBOTT LABORATORIES: COMPANY SNAPSHOT
- TABLE 129. ABBOTT LABORATORIES: PRODUCT SEGMENTS
- TABLE 130. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
- TABLE 131. ABBOTT LABORATORIES: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 01. POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032
- FIGURE 02. SEGMENTATION OF POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032
- FIGURE 03. TOP INVESTMENT POCKETS IN POINT-OF-CARE GLUCOSE TESTING MARKET (2023-2032)
- FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
- FIGURE 05. LOW BARGAINING POWER OF BUYERS
- FIGURE 06. LOW THREAT OF SUBSTITUTES
- FIGURE 07. LOW THREAT OF NEW ENTRANTS
- FIGURE 08. LOW INTENSITY OF RIVALRY
- FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALPOINT-OF-CARE GLUCOSE TESTING MARKET
- FIGURE 10. POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022(%)
- FIGURE 11. COMPARATIVE SHARE ANALYSIS OF POINT-OF-CARE GLUCOSE TESTING MARKET FOR LANCING DEVICES AND STRIPS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 12. COMPARATIVE SHARE ANALYSIS OF POINT-OF-CARE GLUCOSE TESTING MARKET FOR BLOOD-GLUCOSE METER, BY COUNTRY 2022 AND 2032(%)
- FIGURE 13. POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022(%)
- FIGURE 14. COMPARATIVE SHARE ANALYSIS OF POINT-OF-CARE GLUCOSE TESTING MARKET FOR TYPE-1 DIABETES, BY COUNTRY 2022 AND 2032(%)
- FIGURE 15. COMPARATIVE SHARE ANALYSIS OF POINT-OF-CARE GLUCOSE TESTING MARKET FOR TYPE-2 DIABETES, BY COUNTRY 2022 AND 2032(%)
- FIGURE 16. POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022(%)
- FIGURE 17. COMPARATIVE SHARE ANALYSIS OF POINT-OF-CARE GLUCOSE TESTING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 18. COMPARATIVE SHARE ANALYSIS OF POINT-OF-CARE GLUCOSE TESTING MARKET FOR HOME CARE SETTINGS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 19. COMPARATIVE SHARE ANALYSIS OF POINT-OF-CARE GLUCOSE TESTING MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 20. POINT-OF-CARE GLUCOSE TESTING MARKET BY REGION, 2022
- FIGURE 21. U.S. POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032 ($MILLION)
- FIGURE 22. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032 ($MILLION)
- FIGURE 23. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032 ($MILLION)
- FIGURE 24. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032 ($MILLION)
- FIGURE 25. FRANCE POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032 ($MILLION)
- FIGURE 26. UK POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032 ($MILLION)
- FIGURE 27. ITALY POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032 ($MILLION)
- FIGURE 28. SPAIN POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032 ($MILLION)
- FIGURE 29. REST OF EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032 ($MILLION)
- FIGURE 30. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032 ($MILLION)
- FIGURE 31. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032 ($MILLION)
- FIGURE 32. AUSTRALIA POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032 ($MILLION)
- FIGURE 33. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032 ($MILLION)
- FIGURE 34. SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032 ($MILLION)
- FIGURE 35. REST OF ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032 ($MILLION)
- FIGURE 36. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032 ($MILLION)
- FIGURE 37. SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032 ($MILLION)
- FIGURE 38. SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032 ($MILLION)
- FIGURE 39. REST OF LAMEA POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032 ($MILLION)
- FIGURE 40. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 43. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 44. COMPETITIVE DASHBOARD
- FIGURE 45. COMPETITIVE HEATMAP: POINT-OF-CARE GLUCOSE TESTING MARKET
- FIGURE 46. TOP PLAYER POSITIONING, 2022
- FIGURE 47. EKF DIAGNOSTICS HOLDINGS PLC: NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 48. EKF DIAGNOSTICS HOLDINGS PLC: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 49. NIPRO: NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 50. NIPRO: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 51. NIPRO: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 52. F. HOFFMANN-LA ROCHE LTD.: NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 53. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 54. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 55. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
- FIGURE 56. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 57. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2022 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook